Table 1. Follow-up results after Enterprise-assisted stroke revascularization*.
| PtNo. | Pre-NIHSS | TIMI 2/3 | mRS | Barthel @ 2 y | 6-month angiogram | ||||
|---|---|---|---|---|---|---|---|---|---|
| 1 mo | 3 mo | 6 mo | 1 y | 2 y | |||||
| 1 | 9 | 3 | 0 | 0 | 0 | 0 | 0 | 100 | refused |
| 2 | 15 | 3 | 4 | 4 | 4 | 6 | 6 | dead | refused |
| 3 | 16 | 3 | 6 | 6 | 6 | 6 | 6 | dead | dead |
| 4 | 23 | 3 | 6 | 6 | 6 | 6 | 6 | dead | dead |
| 5 | 13 | 2 | 6 | 6 | 6 | 6 | 6 | dead | dead |
| 6 | 21 | 3 | 3 | 3 | 3 | 2 | 2 | 95 | patent, DSA |
| 7 | 17 | 3 | 0 | 0 | 0 | 0 | 0 | 100 | patent, MRA @12 m |
| 8 | 28 | 3 | 6 | 6 | 6 | 6 | 6 | dead | dead |
| 9 | 19 | 3 | 6 | 6 | 6 | 6 | 6 | dead | dead |
| 10 | 25 | 2 | 0 | 0 | 0 | 0 | 0 | 100 | patent, DSA |
| 11 | 12 | 1 | 0 | 0 | 0 | 0 | 0 | 100 | refused |
| 12 | 21 | 0 | 4 | 4 | 4 | 4 | 4 | 70 | patent, CTA |
| 13 | 15 | 3 | 0 | 0 | 0 | 0 | 0 | 100 | patent, DSA |
| 14 | 12 | 2 | 6 | 6 | 6 | 6 | 6 | dead | dead |
| 15 | 9 | 3 | 1 | 1 | 1 | 1 | 1 | 100 | patent, DSA |
| 16 | 8 | 3 | 1 | 1 | 1 | 1 | 1 | 100 | refused |
| 17 | 8 | 2 | 2 | 1 | 1 | 1 | 1 | 100 | patent, CTA |
| 18 | 12 | 2 | 2 | 1 | 1 | 1 | 1 | 100 | patent, DSA |
| 19 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | 100 | patent, DSA |
| 20 | 16 | 6 | 6 | 6 | 6 | 6 | 6 | dead | dead |
Abbreviations: CTA, computed tomographic angiogram; DSA, digital subtraction angiogram; mo, month(s); MRA, magnetic resonance angiogram; mRS, modified Rankin scale; Pre, prestroke intervention; y, year(s).
*
Stents were implanted in patients 2–10, 13, 14, 15, and 17.